J. H. van Snick1*
B. van Leer1,2
M. W. N. Nijsten2
J. Pillay2,3
R. H. J. A. Slart1,4
A. W. J. M. Glaudemans1N. D. van Rijsewijk1- 1Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
- 2Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
- 3Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands
- 4Biomedical Photonic Imaging Group, Faculty of Science and Technology, University of Twente, Enschede, Netherlands
The introduction of new long axial field of view (LAFOV) scanners is a major milestone in positron emission tomography/computed tomography (PET/CT) imaging. With these new systems a revolutionary reduction in scan time can be achieved, concurrently lowering tracer dose. Therefore, PET/CT has come within reach for groups of patients in whom PET/CT previously was undesirable. In this case report we discuss the procedure of a continuous bed motion (CBM) total-body [18F]FDG PET/CT scan in an intensive care patient. We emphasize the clinical and technical possibilities with this new camera system, a matched clinical protocol, and the added value of a dedicated team.
Introduction
The use of 18F-fluoro-deoxy-D-glucose ([18F]FDG) positron emission tomography computed tomography (PET/CT) in infection and inflammation imaging has increased over the last decade. Inflammatory cells and bacteria involved in infectious and inflammatory processes have a high glycolytic rate and therefore result in [18F]FDG accumulation This allows PET/CT to show areas of ongoing infection and inflammation (1, 2).
[18F]FDG PET/CT is of added value for a broad range of infectious and inflammatory causes, such as vasculitis, endocarditis, osteomyelitis and especially when the infection or inflammation is of unknown origin (3, 4). The latter patient category suffers from fever and elevated inflammatory markers while the location of the infection or inflammation remains unknown (5). [18F]FDG PET/CT imaging allows for the determination of foci of infection and/or inflammation, thereby guiding therapy (6, 7).
Although [18F]FDG PET/CT has become an established diagnostic tool in the clinic it is seldomly used within the intensive care setting (8). This is surprising as both infection and inflammation have a high prevalence in this patient population. The two major syndromes defined by infection and inflammation respectively, sepsis and the acute respiratory distress syndrome, comprise 30% of ICU (intensive care unit) admissions (9–11). Furthermore, nosocomial infections occur frequently in critically ill patients contributing to prolonged organ dysfunction and mortality (12–14). In patients with persistent critical illness (i.e., ≥ 10 days of ICU admission) more than 50% develop a new septic episode, frequently with an unknown focus (15–18). The fact that PET/CT is not widely used in ICU patients is due to the perceived complexity of patients, the comprehensive patient preparation and extensive scanning time (8, 19).
Recent advances in PET/CT technology, such as ultra-high sensitivity mode in long axial field of view (LAFOV) PET/CT systems, have led to a dramatic reduction in acquisition time and administered activity (20–23). These technological improvements remove a perceived barrier to more routine use of PET/CT in ICU patients.
In this case report, we demonstrate the use of the new LAFOV PET/CT system in an ICU patient. The technical and clinical aspects and benefits will be discussed.
Case
A 67-year-old female was admitted to the ICU due to a Hemophilus influenza sepsis complicated by a heart tamponade, caused by a pericarditis, resulting in an in-hospital cardiac arrest. Successful resuscitation was achieved by pericardiocentesis and placement of pericardial drains. An arthroscopy with rinsing was performed for a bacterial arthritis of the right knee, from which Hemophilus influenza was cultured. Antibiotic therapy with ceftriaxone was started. Subsequently a contrast enhanced CT scan of the thorax was performed showing a bilateral pleural effusion. After an initial phase of recovery, the patient relapsed with an inflammatory profile including fever and a CRP of 128 mg/L, despite continued antibiotic treatment. To identify possible secondary foci, a request for [18F]FDG PET/CT examination was made with emphasis on the upper airway since all problems had started with a painful throat. Previously no imaging focusing on this area had been performed.
In the nuclear medicine department, a dedicated physician assistant (PA) is available for ICU patients to manage logistics and patient preparation. The patient was prepared following international standards, including 4 h fasting period and discontinuation of glucose infusion (24, 25).
The patient was scheduled with priority the next day on a LAFOV (106 cm) Biograph Vision Quadra PET/CT scanner (Siemens Healthineers, Knoxville, TN, United States). A total of 145 MBq (2 MBq/kg) of [18F]FDG was intravenously administered at the ICU department after checking the blood glucose (6.4 mmol/L). After 30 min, the patient was transferred to nuclear medicine department according to our in-house protocol for transfer of critically ill patients. For transfer from the bed to the scanning table, a hoist mechanism is used. During the scan, the patient was fully sedated, required mechanical ventilation and vasopressor support through multiple intravenous lines. The tubing for the intravenous lines was extended to 2.5 m (26). Prior to the start of the scan, a scan-table movement test was conducted to confirm the placement and unhindered movement of the patient with the lines and tube. Once these checks were confirmed, the PET/CT scan was started 60 min post injection (27).
In order to take full advantage of the new features of the Quadra system, the scan was performed in 12 min continuous bed mode (CBM) and in ultra-high sensitivity (UHS) mode (23). Continuous bed mode facilitates the slow and gentle movement of the scan bed through the gantry, permitting 195 cm to be scanned in one pass without limitation of the 106 cm FOV. In this case, it was crucial to focus not only on the primary area of concern (the throat), but also on the known foci in the knee that required examination. The data were reconstructed with our clinical standard protocol: Ordinary-Poisson Ordered-Subsets Expectation–Maximization and TrueX+TOF (UltraHD-PET) 4 iterations, 5 subsets, matrix 440 × 440 voxel 1.65 × 1.65 mm, no filter, and Ultra High Sensitivity. Images were reviewed by a nuclear medicine specialist in Syngo.Via VB60 using MM-oncology (Siemens Healthineers, Erlangen, Germany) (28).
The [18F]FDG PET/CT did not show an infectious focus in the head and neck area besides some reactive lymph nodes. Furthermore, persisting pericardial fluid without [18F]FDG uptake was seen despite continuous drainage (Figures 1B–D). [18F]FDG enhancement was seen in the pericardial layers, mainly around the right atrium, most likely due to some remaining pericarditis (Figures 1A,B,D). Bilateral pleural effusion did not show [18F]FDG uptake, which was in line with negative cultures of this fluid obtained directly after the PET/CT. However, some increased uptake in the pleural sheets could indicate pleuritis. [18F]FDG uptake was seen in the right cephalic vein indicating a possible thrombophlebitis (Figure 1A). In the synovial space of the right knee clear [18F]FDG enhancement was visible, indicating the earlier diagnosed synovitis (Figures 1A,E,G).
Figure 1. (A) Maximum Intensity Projection (MIP) showing pathological [18F]FDG uptake in the pericardial cavity and right knee (red arrow) and [18F]FDG enhancement in the cephalic vein, possibly caused by a thrombophlebitis (blue arrow). Furthermore, physiological uptake can be seen in the liver, kidneys, and urinary catheter tract. (B–D) Coronal PET, low-dose CT, and PET/CT fusion image of the thorax, respectively, showing clear pericardial effusion (green arrow) with slightly elevated [18F]FDG uptake in the pericardial layers. The pleural effusion showed no tracer uptake. (E–G) Sagittal PET, low-dose CT, and PET/CT fusion image of the right knee (red arrow), respectively, showing increased [18F]FDG uptake in the synovial space due to the Hemophilus Influenza infection.
Concurrently with the PET/CT scan, blood cultures were taken, later showing Enterococcus faecium. The central line was removed shortly before the PET/CT, which later showed to be the source, and vancomycin therapy was started. The [18F]FDG uptake pattern was classified as a reactive remainder of the initial infection. Together with the negative pleural punction and the central line infection as a cause for the deterioration, ceftriaxone and vancomycin treatment was stopped. The patient rapidly recovered.
Discussion
This case illustrates the challenges of performing a PET/CT scan in ICU patients due to the complexity of mechanical ventilation and vasopressor support required by the patient, presence of intravenous lines and the necessary planning, logistics and transport. The added value of performing a [18F]FDG PET/CT scan in ICU patients was demonstrated. Thanks to the PET/CT scan another localization of the Hemophilus influenza could be excluded facilitating safe tapering of antibiotic treatment. However, more importantly, we showed that, with the recent advancement in technology, a PET/CT can be performed relatively easily in ICU patients using a LAFOV PET/CT camera, which is mainly achieved by reduction of the scan time (up to 2 min for one bed position) (29).
Another advantage of the newest function of the LAFOV PET/CT system is the added value of scanning in CBM mode, allowing to scan a total body while the table moves gently and remains comfortable for the patient, with also less risk for lines and tubes to get stuck or tangled compared to scanning total body using the multiple bed positions method. This bed position method is used in older type of scanners, statically scanning one bed position before moving to the next, resulting in relatively sudden movements between positions. Besides, it needs large overlap in bed positions for sufficient fusion between the low dose CT and PET scan, demanding more acquisition time.
In this case, a total acquisition time of 12 min was used since this was the first time an ICU patient was scanned using the LAFOV PET/CT system in CBM mode. By further adapting the procedure, a total of 6–7 min acquisition time seems to be feasible in this patient group, without compromising image quality and diagnostic value. In comparison, the acquisition time would have been approximately 30 min on a conventional PET/CT system. Furthermore, due to the limited sensitivity of conventional PET/CT’s, a higher radioactivity dose must be administered with these types of camera systems. This results not only in a higher radiation dose for the patient but also for the ICU staff (30, 31). A dose reduction as low as 1 MBq/kg for a LAFOV PET/CT has already been suggested (20).
The successful execution of an [18F]FDG PET/CT procedure for critically ill patients requires a specialized team with sufficient experience and expertise. Key members of this team include an ICU physician, an ICU nurse and competent PET/CT technologists. Furthermore, it is crucial to have a dedicated facilitator to ensure smooth communication and coordination between the two departments. This role is fulfilled in our institution using a physician assistant of the nuclear medicine department. Furthermore, a standard operating procedure should be available for both departments.
In conclusion, the utilization of LAFOV PET/CT yields a nearly similar duration for transport and scanning when compared with an ordinary CT scan. Therefore, using this system, PET/CT has become more accessible for use in critically ill patients. However, before implementation, perceived barriers in scanning complex ICU patients need to be addressed by research into safety, patient preparation, and logistics. Eventually, this may result in international practice guidelines.
Data availability statement
The datasets presented in this article are not readily available because the raw data is protected by privacy laws. Fully anonymized data is available on reasonable request. Requests to access the datasets should be directed to the corresponding author.
Ethics statement
The requirement of ethical approval was waived by Medical ethical committee UMCG for the studies involving humans. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
JS: Conceptualization, Methodology, Writing – original draft. BL: Conceptualization, Supervision, Writing – review & editing. MN: Writing – review & editing. JP: Writing – review & editing. RS: Writing – review & editing. AG: Supervision, Writing – review & editing. NR: Conceptualization, Supervision, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. JP is supported by a research grant from the Netherlands Organization for Health Research and Development, the Netherlands (ZonMw Clinical Fellowship grant 09032212110044).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Partnership of UMCG-Siemens for building the future of Health (PUSH). Siemens was not involved in the imaging process nor in the writing phase of this case.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Abbreviations
[18F]FDG, 2-18F-fluoro-deoxy-D-glucose; CT, Computed Tomography; LAFOV, Long Axial Field of View; PET, Positron Emission Tomography; ICU, Intensive Care Unit
References
1. Annunziata, S , Treglia, G , Jamar, F , Lauri, C , Palestro, CJ , Gheysens, O, et al. Nuclear medicine practice in the field of infection and inflammation imaging: a pragmatical survey. Eur J Nucl Med Mol Imaging. (2022) 49:2113–9. doi: 10.1007/s00259-022-05725-9
2. Lawal, IO , Gheysens, O , Sathekge, MM , and Glaudemans, AWJM . Editorial: functional imaging of inflammation and infection. Front Med (Lausanne). (2022) 9:925635. doi: 10.3389/fmed.2022.925635
3. Slart, RHJA , Glaudemans, AWJM , Gheysens, O , Lubberink, M , Kero, T , Dweck, MR, et al. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM. Eur J Nucl Med Mol Imaging. (2021) 48:1016–39. doi: 10.1007/s00259-020-05066-5
4. ten Hove, D , Slart, RHJA , Sinha, B , Glaudemans, AWJM , and Budde, RPJ . 18F-FDG PET/CT in infective endocarditis: indications and approaches for standardization. Curr Cardiol Rep. (2021) 23:130. doi: 10.1007/s11886-021-01542-y
5. van Rijsewijk, ND , IJpma, FFA , Wouthuyzen-Bakker, M , and Glaudemans, AWJM . Molecular imaging of fever of unknown origin: an update. Semin Nucl Med. (2023) 53:4–17. doi: 10.1053/j.semnuclmed.2022.07.002
6. Ropers, FG , van Mossevelde, RMP , Bleeker-Rovers, CP , van Velden, FHP , van Assema, DME , Adam, JA, et al. Evaluation of FDG-PET/CT use in children with suspected infection or inflammation. Diagnostics. (2020) 10:715. doi: 10.3390/diagnostics10090715
7. Medvedeva, N , Radcliffe, C , Malinis, M , Chen, M-K , and Azar, MM . Real-world assessment of the clinical utility of whole body 18F-FDG PET/CT in the diagnosis of infection. PLoS One. (2022) 17:e0277403. doi: 10.1371/journal.pone.0277403
8. van Leer, B , van Rijsewijk, ND , Nijsten, MWN , Slart, RHJA , Pillay, J , and Glaudemans, AWJM . Practice of 18F-FDG-PET/CT in ICU patients: a systematic review. Semin Nucl Med. (2023) 53:809–19. doi: 10.1053/j.semnuclmed.2023.05.003
9. Sakr, Y , Jaschinski, U , Wittebole, X , Szakmany, T , Lipman, J , Ñamendys-Silva, SA, et al. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis. (2018) 5:ofy313. doi: 10.1093/ofid/ofy313
10. Bellani, G , Laffey, JG , Pham, T , Fan, E , Brochard, L , Esteban, A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. (2016) 315:788–800. doi: 10.1001/jama.2016.0291
11. Hendrickson, KW , Peltan, ID , and Brown, SM . The epidemiology of acute respiratory distress syndrome before and after coronavirus disease 2019. Crit Care Clin. (2021) 37:703–16. doi: 10.1016/j.ccc.2021.05.001
12. Blot, S , Ruppé, E , Harbarth, S , Asehnoune, K , Poulakou, G , Luyt, CE, et al. Healthcare-associated infections in adult intensive care unit patients: changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs. (2022) 70:103227. doi: 10.1016/j.iccn.2022.103227
13. Prowle, JR , Echeverri, JE , Ligabo, EV , Sherry, N , Taori, GC , Crozier, TM, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care. (2011) 15:R100. doi: 10.1186/cc10114
14. Talmor, M . Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness. Arch Surg. (1999) 134:81–7. doi: 10.1001/archsurg.134.1.81
15. Kalb, TH , and Lorin, S . Infection in the chronically critically ill: unique risk profile in a newly defined population. Crit Care Clin. (2002) 18:529–52. doi: 10.1016/S0749-0704(02)00009-X
16. Iwashyna, TJ , Hodgson, CL , Pilcher, D , Bailey, M , van Lint, A , Chavan, S, et al. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study. Lancet Respir Med. (2016) 4:566–73. doi: 10.1016/S2213-2600(16)30098-4
17. Nedeva, C , Menassa, J , and Puthalakath, H . Sepsis: inflammation is a necessary evil. Front Cell Dev Biol. (2019) 7:108. doi: 10.3389/fcell.2019.00108
18. Van Vught, LAV , Klein Klouwenberg, PM , Spitoni, C , Scicluna, BP , Wiewel, MA , Horn, J, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. (2016) 315:1469–79. doi: 10.1001/jama.2016.2691
19. Van Hulst, A. , Van Hulst, A. M. , Van Rijk, M. C. , Bavelaar-Croon, C. D. L. , and Tjan, D. H. T. , “The value of F-18-fluorodeoxyglucose positron emission tomography (FDG-PET/CT) in the intensive care unit: a review Netherlands journal of critical care the value of F-18-fluorodeoxyglucose positron emission tomography (FDG-PET/CT) in the intensive care unit: A review,” (2019). [Online]. Available at: https://www.researchgate.net/publication/362134916
20. Calderón, E , Schmidt, FP , Lan, W , Castaneda-Vega, S , Brendlin, AS , Trautwein, NF, et al. Image quality and quantitative PET parameters of low-dose [18F]FDG PET in a long axial field-of-view PET/CT scanner. Diagnostics. (2023) 13:3240. doi: 10.3390/diagnostics13203240
21. Alberts, I , Sari, H , Mingels, C , Afshar-Oromieh, A , Pyka, T , Shi, K, et al. Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients. Cancer Imaging. (2023) 23:28. doi: 10.1186/s40644-023-00540-3
22. Sachpekidis, C , Pan, L , Kopp-Schneider, A , Weru, V , Hassel, JC , and Dimitrakopoulou-Strauss, A . Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma. Eur J Nucl Med Mol Imaging. (2023) 50:1158–67. doi: 10.1007/s00259-022-06070-7
23. Mingels, C , Weidner, S , Sari, H , Buesser, D , Zeimpekis, K , Shi, K, et al. Impact of the new ultra-high sensitivity mode in a long axial field-of-view PET/CT. Ann Nucl Med. (2023) 37:310–5. doi: 10.1007/s12149-023-01827-y
24. Nakatani, K , Nakamoto, Y , and Togashi, K . Risk factors for extensive skeletal muscle uptake in oncologic FDG-PET/CT for patients undergoing a 4-h fast. Nucl Med Commun. (2012) 33:648–55. doi: 10.1097/MNM.0b013e328352290f
25. Kaneta, T , Hakamatsuka, T , Takanami, K , Yamada, T , Takase, K , Sato, A, et al. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization. Ann Nucl Med. (2006) 20:203–8. doi: 10.1007/BF03027431
26. “Biograph Vision Quadra PET/CT Scanner-Siemens Healthineers-Siemens Healthineers .” [Online]. Available: https://www.siemens-healthineers.com/molecular-imaging/pet-ct/biograph-vision-quadra (Accessed November 23, 2023)
27. Boellaard, R , Delgado-Bolton, R , Oyen, WJ , Giammarile, F , Tatsch, K , Eschner, W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. (2015) 42:328–54. doi: 10.1007/s00259-014-2961-x
28. “syngo.via imaging software for advanced visualization by Siemens Healthineers | Open Inventor 3D SDK .” [Online]. Available at: https://www.openinventor.com/en/about/user-testimonials/detail/syngo-via-imaging-software-for-advanced-visualization-by-siemens-healthineers (Accessed November 23, 2023)
29. He, Y , Gu, Y , Yu, H , Wu, B , Wang, S , Tan, H, et al. Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose 18F-fluorodeoxyglucose in oncology patients. EJNMMI Phys. (2022) 9:45. doi: 10.1186/s40658-022-00474-y
30. Leide-Svegborn, S . Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG. Radiat Prot Dosim. (2010) 139:208–13. doi: 10.1093/rpd/ncq026
Keywords: CT, ICU patient, critically ill, imaging procedure, nuclear medicine, PET, FDG
Citation: van Snick JH, van Leer B, Nijsten MWN, Pillay J, Slart RHJA, Glaudemans AWJM and van Rijsewijk ND (2024) Long axial field of view PET/CT in critically ill patients: lessons from a case report. Front. Med. 10:1347791. doi: 10.3389/fmed.2023.1347791
Edited by:
Carmelo Caldarella, Fondazione Policlinico Universitario A. Gemelli IRCCS, ItalyReviewed by:
Domenico Albano, University of Brescia, ItalyGiorgio Treglia, Ente Ospedaliero Cantonale (EOC), Switzerland
Copyright © 2024 van Snick, van Leer, Nijsten, Pillay, Slart, Glaudemans and van Rijsewijk. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: J. H. van Snick, j.h.van.snick@umcg.nl